New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture

European Respiratory Journal

Volumn 30, Issue 3, 2007, Pages 501-507

  Ritchie, S R ^a   Harrison, A C ^a   Vaughan, R H ^a   Calder, L ^b   Morris, A J ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Auckland Regional Public Health Service   (New Zealand)

Author keywords

Infectivity; Pulmonary tuberculosis; Respiratory isolation; Time to detect tuberculosis in liquid culture; Transmission; Treatment

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INOCULATION; LIQUID CULTURE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM SMEAR; DISEASE TRANSMISSION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LENGTH OF STAY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEW ZEALAND; PATIENT CARE; RETROSPECTIVE STUDY; SPUTUM; STATISTICS; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; FEMALE; HUMANS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NEW ZEALAND; PATIENT ISOLATION; RETROSPECTIVE STUDIES; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 38449103262     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00131406     Document Type: Article

References (23)

1. Iseman MD. An unholy trinity - three negative sputum smears and release from tuberculosis isolation. Clin Infect Dis 1997; 25: 671-672.
2. Paterson A, McEnnis V, Martin P, Calder L, Harrison AC. Infection control in tuberculosis. In: New Zealand Ministry of Health. Guidelines for Tuberculosis Control in New Zealand, 2003. www.moh.govt.nz/moh.nsf/0/ 4760DF3580A6F5B5CC256C86006ED394/$File/9.InfectioncontrolinTB.pdf Date last accessed: September 2006.
3. Jensen PA, Lambert LA, Iademarco MF, Ridzon R, CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005; 54: 1-141.
4. Taylor Z, Nolan CM, Blumberg HM, American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005; 54: 1-81.
5. Sepkowitz KA. How contagious is tuberculosis? Clin Infect Dis 1996; 23: 954-962.
6. Liippo KK, Kulmala K, Tala EO. Focusing tuberculosis contact tracing by smear grading of index cases. Am Rev Respir Dis 1993; 148: 235-236.
7. Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954; 69: 724-732.
8. Davies BH. Infectivity of tuberculosis. Thorax 1980; 35: 481-482.
9. Hobby GL, Holman AP, Iseman MD, Jones JM. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother 1973; 4: 94-104.
10. Yeager H, Lacy J, Smith LR, LeMaistre CA. Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis 1967; 95: 998-1004.
11. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449.
12. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980; 121: 939-949.
13. Jindani A, Doré CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003; 167: 1348-1354.
14. Pfyffer GE, Brown-Elliott BA, Wallace RJ. Mycobacterium: general characteristics, isolation and staining procedures. In: Murray PR, Barron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology. 8th Edn. Washington, ASM Press, 2003; pp. 532-559.
15. Mixides G, Shende V, Teeter LD, Awe R, Musser JM, Graviss EA. Number of negative acid-fast smears needed to adequately assess infectivity of patients with pulmonary tuberculosis. Chest 2005; 128: 108-115.
16. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1998; 53: 536-548.
17. Al-Moamary MS, Black W, Bessuille E, Elwood RK, Vedal S. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest 1999; 116: 726-731.
18. Winters RE. Guidelines for preventing the transmission of tuberculosis: a better solution? Clin Infect Dis 1994; 19: 309-310.
19. Epstein MD, Schluger NW, Davidow AL, Bonk S, Rom WN, Hanna B. Time to detection of Mycobacterium tuberculosis in sputumculture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest 1998; 113: 379-386.
20. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000; 162: 2033-2038.
21. Long R, Bochar K, Chomyc S, et al. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment. Infect Control Hosp Epidemiol 2003; 24: 831-838.
22. Gunnels JJ, Bates JH, Swindoll H. Infectivity of sputum-positive tuberculous patients on chemotherapy. Am Rev Respir Dis 1974; 109: 323-330.
23. Kamat SR, Dawson JJ, Devadatta S, et al. A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bull World Health Organ 1966; 34: 517-532.